CYBERKNIFE SYSTEM

Left Upper Lobe Lung Metastasis

Case History

AGE: 64-year-old
GENDER: Male

Medical History

  • Chronic obstructive pulmonary disease (COPD), previous surgery on left lung
  • Chest CT: Suspicious lesion in the left upper lobe
  • PET-CT: hypermetabolic nodule, 1.8cm no evidence of regional or distant metastasis

Hypertension and smoker with a 65-pack-year history. Persistent cough and unintentional weight loss over the past three months

Non-small cell lung cancer (NSCLC) adenocarcinoma cT1bN0M0, Stage IA2

Planning CT Images

Treatment Plan Images

Treatment Planning Highlights

Fractionation

50 Gy in 5 fractions

PTV(s) Volume

PTV, 5.17 cc

Dose Distributions

  • Prescription to the
    71.7% isodose line
  • Max. dose 69.7 Gy

Collimator

InCise™ MLC

Dose Calculation Algorithm

Monte Carlo

New Conformality Index (nCI)

nCi = 1.51

Gradient Index (GI)

GI = 4.51

Protocol Used

RECORAD

Treatment Delivery Information

Tracking Method

Lung 1 View with Respiratory Modelling

Total Delivery Time

22 minutes

Medical Affairs

Accuray Medical Affairs serves as your comprehensive resource hub for clinical evidence, and peer collaboration through our user community.

Services

Industry-leading service to support your ongoing success, from speedy install and optimization, to proactive monitoring and unrivalled on-site service, to smart upgrade paths to keep your system at the leading edge.

Solutions

From robotic to helical radiation therapy delivery, we invent unique, market-changing solutions that are designed to deliver radiation treatments across a full spectrum of patient needs.

Treatment Centers

Radiosurgery

Adaptive Radiotherapy

What's New

Your go-to source for staying informed about our advancements.

Why Accuray

Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond.